Thiazolidinediones and inflammation by Consoli, A, Devangelio, E

Get full text

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects by Derosa, G, D’Angelo, A, Tinelli, C, Devangelio, E, Consoli, A, Miccoli, R, Penno, G, Del Prato, S, Paniga, S, Cicero, A.F.G

Get full text

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study by Fadini, G. P., Li Volsi, P., Devangelio, E., Poli, M., Cazzetta, G., Felace, G., Avogaro, A.

Get full text

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity by Fadini, G P, Zatti, G, Consoli, A, Bonora, E, Sesti, G, Avogaro, A

Get full text

Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus by Santilli, Francesca, Davì, Giovanni, Consoli, Agostino, Cipollone, Francesco, Mezzetti, Andrea, Falco, Angela, Taraborelli, Tea, Devangelio, Eleonora, Ciabattoni, Giovanni, Basili, Stefania, Patrono, Carlo

Get full text

The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy by Vaccaro, O, Boemi, M, Cavalot, F, De Feo, P, Miccoli, R, Patti, L, Rivellese, A.A, Trovati, M, Ardigò, D, Zavaroni, I

Get full text

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) by Fadini, G.P., Zatti, G., Consoli, A., Bonora, E., Sesti, G., Avogaro, A., Consoli, A., Formoso, G., Antenucci, D., Grossi, G., Pucci, A., Sesti, G., Andreozzi, F., Indrieri, L., Capobianco, G., Gatti, A., Bonadonna, R., Zavaroni, I., Dei Cas, A., Felace, G., Li Volsi, P., Buzzetti, R., Leto, G., D'Angelo, F., Morano, S., Giaccari, A., Sorice, G., Orsi, E., Carlo Bossi, A., Querci, F., Duratorre, E., Malagola, C., Franzetti, I., Silvia Morpurgo, P., Boemi, M., Petrelli, M., Aimaretti, G., Karamouzis, I., Cavalot, F., Saglietti, G., Gruden, G., Devangelio, E., Cazzetta, G., Lamacchia, O., Cervone, S., Frittitta, L., Arena, S., Di Benedetto, A., Piro, S., Giordano, C., Rizzo, M., Chianetta, R., Mannina, C., Solini, A., Natali, A., Anichini, R., Dotta, F., Fattor, B., Avogaro, A., Fadini, G.P., Bonora, E., Cigolini, M., Simioni, N., Frison, V., Poli, M., Lapolla, A., Cristiano Chilelli, N., Vinci, C.

Get full text

We-P11:43 Decreased levels of soluble receptor for advanced glycation end products in type 2 diabetes: Association with oxidative stress and metabolic control by Santilli, F., Devangelio, E., Formoso, G., Ferroni, P., Bucciarelli, L., Mchetti, N., Clissa, C., Ciabattoni, G., Consoli, A., Davì, G.

Get full text

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study by Morieri, M. L., Raz, I., Consoli, A., Rigato, M., Lapolla, A., Broglio, F., Bonora, E., Avogaro, A., Fadini, G. P.

Get full text